布里莫尼丁在近视治疗中的潜力:准MMP-2以调节胸膜厚度和控制眼睛生长
Aiqun Xiang1, Zixuan Peng2, Hong He2
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.
Heliyon
|September 23, 2024
概括
布里莫尼丁治疗有效地减少近视的进展在试验猪通过防止胆道细化和保持MMP-2表达. 这表明近视控制的潜在治疗应用.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 近视的进展是一个重大问题,药物治疗是关键的研究领域.
- 形状缺失近视 (FDM) 模型对于研究近视发展和潜在干预措施至关重要.
研究的目的:
- 为了研究布里莫尼丁对近视进展,MMP-2和COL1A1表达在几内亚猪的影响.
- 在FDM模型中探索布里莫尼丁对RPE-choroid复合体和硬膜的影响.
主要方法:
- 在几内亚猪FDM模型中使用了不同度和路径的布里莫尼丁.
- 评估了近视进展,MMP-2和COL1A1表达的变化.
- 研究了对视网膜色素上皮质 (RPE) - 冠状腺复合体和膜的影响.
主要成果:
- 布里莫尼丁阻碍了FDM诱导的冠状腺稀疏,可能是通过血管扩张.
- 布里莫尼丁抵消了FDM诱导的MMP-2表达在胆膜和膜中的下调.
- 减少MMP-2抑制可以保持结构完整性和眼球血流,减轻延长.
结论:
- 布里莫尼丁在缓解近视进展方面表现出潜力.
- 药物对MMP-2和胆道结构的影响为近视治疗策略提供了洞察力.
相关概念视频
Open Angle Glaucoma: Treatment
406
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
406
Angle Closure Glaucoma: Treatment
451
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
451
Direct-Acting Cholinergic Agonists: Therapeutic Uses
702
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
702
Glaucoma: Overview
528
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
528
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
542
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
542


